This inventor holds 1 USPTO granted patent. Top assignee: Bayer Schering Pharma Ag. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Santiago Figureoa Perez: Innovator in Medicinal Chemistry
Introduction
Santiago Figureoa Perez is a notable inventor based in Leverkusen, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for treating cardiovascular disorders. His innovative work has led to the filing of a patent that showcases his expertise and dedication to improving healthcare.
Latest Patents
Santiago Figureoa Perez holds a patent for "Substituted phenylamino-pyrimidines." This invention relates to substituted phenylaminopyrimidines, a process for their preparation, and their use in creating medicaments for the treatment and/or prophylaxis of diseases in humans and animals, especially cardiovascular disorders. This patent highlights his commitment to advancing medical treatments and improving patient outcomes. He has 1 patent to his name.
Career Highlights
Santiago Figureoa Perez is associated with Bayer Schering Pharma AG, a leading global pharmaceutical company. His role at Bayer has allowed him to work on groundbreaking research and development projects that aim to address critical health issues. His contributions have been instrumental in the company's efforts to innovate and provide effective solutions in the pharmaceutical industry.
Collaborations
Throughout his career, Santiago has collaborated with esteemed colleagues, including Dieter Lang and Joachim Mittendorf. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, ultimately leading to advancements in their respective fields.
Conclusion
Santiago Figureoa Perez exemplifies the spirit of innovation in the pharmaceutical industry. His work on substituted phenylamino-pyrimidines demonstrates his commitment to improving healthcare through scientific research and development. His contributions will undoubtedly have a lasting impact on the treatment of cardiovascular disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
